Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Doi

Showing results (611-620 of 635) with videos related to

Pageof 64
Sort By:
British Journal of Cancer|May 24, 2012
KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancerY Kawamoto, K Tsuchihara, T Yoshino, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2010
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumorsT Doi, H Murakami, A Ohtsu, et al.
ESMO Open|December 1, 2024
A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumorsH-J Lenz, G Argilés, M J A de Jonge, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1981
Total synthesis of a RNA molecule with sequence identical to that of Escherichia coli formylmethionine tRNAE Ohtsuka, S Tanaka, T Tanaka, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2013
Paediatric presentation and outcome of congenital protein C deficiency in JapanS Ohga, D Kang, T Kinjo, et al.
Oncogene|September 28, 1999
Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalphaA Togawa, J Miyoshi, H Ishizaki, et al.
Nucleic Acids Symposium Series|January 1, 1980
Total synthesis of tRNAfMetE Ohtsuka, A F Markham, S Tanaka, et al.
British Journal of Pharmacology|September 2, 2009
Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivoT Kanke, M Kabeya, S Kubo, et al.
ESMO Open|December 1, 2022
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancerE Van Cutsem, H Hochster, K Shitara, et al.
ESMO Open|June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS studyJ Tabernero, K Shitara, A Zaanan, et al.
Pageof 64

Showing results (611-620 of 635) with videos related to

Sort By:
Pageof 64
British Journal of Cancer|May 24, 2012
KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancerY Kawamoto, K Tsuchihara, T Yoshino, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2010
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumorsT Doi, H Murakami, A Ohtsu, et al.
ESMO Open|December 1, 2024
A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumorsH-J Lenz, G Argilés, M J A de Jonge, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1981
Total synthesis of a RNA molecule with sequence identical to that of Escherichia coli formylmethionine tRNAE Ohtsuka, S Tanaka, T Tanaka, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2013
Paediatric presentation and outcome of congenital protein C deficiency in JapanS Ohga, D Kang, T Kinjo, et al.
Oncogene|September 28, 1999
Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalphaA Togawa, J Miyoshi, H Ishizaki, et al.
Nucleic Acids Symposium Series|January 1, 1980
Total synthesis of tRNAfMetE Ohtsuka, A F Markham, S Tanaka, et al.
British Journal of Pharmacology|September 2, 2009
Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivoT Kanke, M Kabeya, S Kubo, et al.
ESMO Open|December 1, 2022
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancerE Van Cutsem, H Hochster, K Shitara, et al.
ESMO Open|June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS studyJ Tabernero, K Shitara, A Zaanan, et al.
Pageof 64